SCHEMBL26404104

SCHEMBL26404104

CCOC(=O)C(F)(F)Sc1[nH]c(=O)cc(C)c1C#N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.57
▸ TDP1 Q9NUW8 2/20 0.57
▸ TSHR P16473 1/20 0.54
▸ ALDH1A1 P00352 8/20 0.49
▸ KMT2A Q03164 5/20 0.48
▸ HTT P42858 4/20 0.47
▸ GAA P10253 2/20 0.46
▸ LMNA P02545 4/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ TP53 P04637 1/20 0.46
▸ ALOX15 P16050 1/20 0.45
▸ UPP1 Q16831 1/20 0.45
▸ MEN1 O00255 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CRHBP P24387 1/20 0.44
▸ CRHR2 Q13324 1/20 0.44
▸ KDM4E B2RXH2 4/20 0.43
▸ RECQL P46063 1/20 0.42
▸ PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20340057 0.88 KDM4E (0.58) HPGDTDP1TSHRALDH1A1KMT2A
SCHEMBL26404106 0.84 TSHR (0.56) HPGDTDP1TSHRALDH1A1KMT2A
SCHEMBL26404089 0.77 HPGD (0.58) HPGDTDP1TSHRALDH1A1KMT2A
SCHEMBL23183510 0.70 TSHR (0.80) HPGDTDP1TSHRALDH1A1KMT2A
SCHEMBL14110759 0.70 TSHR (1.00) HPGDTDP1TSHRALDH1A1KMT2A
SCHEMBL26404201 0.70 TSHR (0.74) HPGDTDP1TSHRALDH1A1KMT2A
SCHEMBL20350874 0.69 TSHR (0.58) HPGDTDP1TSHRALDH1A1KMT2A
SCHEMBL20340052 0.69 KDM4E (0.57) HPGDTDP1TSHRALDH1A1KMT2A
SCHEMBL26404093 0.69 TSHR (0.56) HPGDTDP1TSHRALDH1A1KMT2A
SCHEMBL26403803 0.69 TSHR (0.67) HPGDTDP1TSHRALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ORSOBIO, INC. (US) 2023-10-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ALDH7A1, ACMSD, AMD1 HPGD 311/4885TDP1 986/4885TSHR 4389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback